<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35385854</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1533-0311</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>44</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
              <Day>01</Day>
            </PubDate>
          </JournalIssue>
          <Title>The American Journal of dermatopathology</Title>
          <ISOAbbreviation>Am J Dermatopathol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Mycobacterium leprae Immunostaining Pitfall.</ArticleTitle>
        <Pagination>
          <StartPage>465</StartPage>
          <EndPage>466</EndPage>
          <MedlinePgn>465-466</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1097/DAD.0000000000002197</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kaur</LastName>
            <ForeName>Harsimran</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, URMC, Rochester, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Goode</LastName>
            <ForeName>William Timothy</ForeName>
            <Initials>WT</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Niagara Associates, Rochester, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Scott</LastName>
            <ForeName>Glynis</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, URMC, Rochester, NY.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, URMC, Rochester, NY.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>06</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Am J Dermatopathol</MedlineTA>
        <NlmUniqueID>7911005</NlmUniqueID>
        <ISSNLinking>0193-1091</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009166" MajorTopicYN="Y">Mycobacterium leprae</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>6</Day>
          <Hour>20</Hour>
          <Minute>6</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35385854</ArticleId>
        <ArticleId IdType="doi">10.1097/DAD.0000000000002197</ArticleId>
        <ArticleId IdType="pii">00000372-202206000-00016</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Report of the Global Forum on Elimination of Leprosy as a Public Health Problem. [WHO Web Site]. Available at: http://www.who.int/lep/en/. Accessed May 2006.</Citation>
        </Reference>
        <Reference>
          <Citation>Anderson H, Stryjewska B, Boyanton BL, et al. Hansen disease in the United States in the 21st century: a review of the literature. Arch Pathol Lab Med. 2007;131:982–986.</Citation>
        </Reference>
        <Reference>
          <Citation>Weedon D Cutaneous infections and infestations: histological patterns. Bacterial and Rickettsial infectios. In: Weedon's, Skin Pathology. 3rd ed Philadelphia, PA: Lippincott Williams &amp; Wilkins; 2010:562–566.</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization. Leprosy (Hansen's Disease). Available at: https://www.who.int/news-room/fact- sheets/detail/leprosy. Accessed May 24, 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Moschella SL. An update on the diagnosis and treatment of leprosy. J Am Acad Dermatol. 2004;51:417.</Citation>
        </Reference>
        <Reference>
          <Citation>Scollard DM, Adams LB, Gillis TP, et al. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338.</Citation>
        </Reference>
        <Reference>
          <Citation>Ridley DS. Histological classification and the immunological spectrum of leprosy. Bull World Health Organ 1974;51:451–465.</Citation>
        </Reference>
        <Reference>
          <Citation>Payne DA, Vander Straten M, Carrasco D, et al. Molecular diagnosis of skin-associated infectious agents. Arch Dermatol. 2001;137:1497–1502.</Citation>
        </Reference>
        <Reference>
          <Citation>Fernandez-Flores A. Immunostaining for Treponema pallidum: caution in its evaluation. Am J Dermatopathol 2010;32:523–525.</Citation>
        </Reference>
        <Reference>
          <Citation>Aparicio MA, Santos-Briz A. Unexpected immunostaining of Mycobaterium leprae with a polyclonal antibody against Treponema pallidum. Am J Dermatopathol 2012;34:559–561.</Citation>
        </Reference>
        <Reference>
          <Citation>Siqueira SAC, Wakamatsu A, Alves VAF, et al. Commercially available anti-S-100 protein serum stains M. leprae in leprosy tissues by immunohisatochemical procedures. Rev Inst Med Trop S Paulo 1990;32:70–71.</Citation>
        </Reference>
        <Reference>
          <Citation>Liu X, Hameed O. Treponema pallidum immunostain distinguishing syphilitic gastritis from Helicobacter pylori-associated gastritis. Hum Pathol. 2010;41:617–619.</Citation>
        </Reference>
        <Reference>
          <Citation>Chung KY, Lee MG, Chon CY, et al. Syphilitic gastritis: demonstration of Treponema pallidumwith the use of fluorescent treponemal antibody absorption complement and immunoperoxidase stains. J Am Acad Dermatol. 1989;21:183–185.</Citation>
        </Reference>
        <Reference>
          <Citation>Tanahashi J, Daa T, Gamachi A, et al. Human intestinal spirochetosis in Japan; its incidence, clinicopathologic features, and genotypic identification. Mod Pathol. 2008;21:76–84.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
